Santaris Pharma

SANTARIS PHARMA A/S

corporate_fareorganization

Web page: http://www.santaris.com

Country: Denmark

Santaris Pharma

- Funding / Projects
  (3)

3 Projects, page 1 of 1

CARDIOMIR (Development of microRNA Medicines for Cardiac Metabolic Diseases; A Targeted European Exchange Programme)
assignment_turned_inProject2012 - 2015Partners:ULiège, UM, Cenix BioScience (Germany), Santaris Pharma
ULiège,
UM,
Cenix BioScience (Germany),
Santaris Pharma
Funder: European Commission Project Code: 285991
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
ATHERO-FLUX (Targeting novel lipid pathways for treatment of cardiovascular disease)
Open Access Mandate for Publications assignment_turned_inProject2013 - 2019Partners:SITOOLS, BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS, Weizmann Institute of Science, Institut Pasteur, TAUH +9 partners
SITOOLS,
BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS,
Weizmann Institute of Science,
Institut Pasteur,
TAUH ,
Pirkanmaa Hospital District,
Santaris Pharma,
Academy of Athens,
SDU,
Cenix BioScience (Germany),
KI,
UOXF,
ALTA SRLU,
Zora Biosciences (Finland)
Funder: European Commission Project Code: 602222
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
ATHERO-B-CELL (Targeting and exploiting B cell functions for treatment in cardiovascular disease)
Open Access Mandate for Publications assignment_turned_inProject2013 - 2018Partners:Santaris Pharma, UCL, ALTA SRLU, Lund University, Goa University +6 partners
Santaris Pharma,
UCL,
ALTA SRLU,
Lund University,
Goa University,
UMC,
BERING LIMITED,
KI,
UOXF,
Genoway (France),
UNIGE
Funder: European Commission Project Code: 602114
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

Santaris Pharma

Santaris Pharma

3 Projects, page 1 of 1

CARDIOMIR (Development of microRNA Medicines for Cardiac Metabolic Diseases; A Targeted European Exchange Programme)

ATHERO-FLUX (Targeting novel lipid pathways for treatment of cardiovascular disease)

ATHERO-B-CELL (Targeting and exploiting B cell functions for treatment in cardiovascular disease)

Loading